HUE056604T2 - Eljárás glikózaminoglikánok, heparinok és származékaik elemzésére nukleáris mágneses rezonanciával - Google Patents

Eljárás glikózaminoglikánok, heparinok és származékaik elemzésére nukleáris mágneses rezonanciával

Info

Publication number
HUE056604T2
HUE056604T2 HUE17749132A HUE17749132A HUE056604T2 HU E056604 T2 HUE056604 T2 HU E056604T2 HU E17749132 A HUE17749132 A HU E17749132A HU E17749132 A HUE17749132 A HU E17749132A HU E056604 T2 HUE056604 T2 HU E056604T2
Authority
HU
Hungary
Prior art keywords
heparins
glycosaminoglycans
derivatives
analysis
magnetic resonance
Prior art date
Application number
HUE17749132A
Other languages
English (en)
Inventor
Guillermo Franco
Ibon Gutierro
Original Assignee
Farm Rovi Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farm Rovi Lab Sa filed Critical Farm Rovi Lab Sa
Publication of HUE056604T2 publication Critical patent/HUE056604T2/hu

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G01N24/087Structure determination of a chemical compound, e.g. of a biomolecule such as a protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46NMR spectroscopy
    • G01R33/4625Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46NMR spectroscopy
    • G01R33/4633Sequences for multi-dimensional NMR

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Signal Processing (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HUE17749132A 2016-07-19 2017-07-19 Eljárás glikózaminoglikánok, heparinok és származékaik elemzésére nukleáris mágneses rezonanciával HUE056604T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16382350.3A EP3273239A1 (en) 2016-07-19 2016-07-19 Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance

Publications (1)

Publication Number Publication Date
HUE056604T2 true HUE056604T2 (hu) 2022-02-28

Family

ID=56682072

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17749132A HUE056604T2 (hu) 2016-07-19 2017-07-19 Eljárás glikózaminoglikánok, heparinok és származékaik elemzésére nukleáris mágneses rezonanciával

Country Status (27)

Country Link
US (2) US10705037B2 (hu)
EP (2) EP3273239A1 (hu)
JP (1) JP7035007B2 (hu)
CN (1) CN109477829B (hu)
AR (1) AR109099A1 (hu)
AU (1) AU2017299186C1 (hu)
BR (1) BR112019000437A2 (hu)
CA (1) CA3029924A1 (hu)
CL (1) CL2019000038A1 (hu)
CO (1) CO2019000087A2 (hu)
CR (1) CR20190016A (hu)
CY (1) CY1124817T1 (hu)
DK (1) DK3452827T3 (hu)
DO (1) DOP2019000003A (hu)
EA (1) EA037102B1 (hu)
ES (1) ES2894898T3 (hu)
HR (1) HRP20211649T1 (hu)
HU (1) HUE056604T2 (hu)
LT (1) LT3452827T (hu)
MA (1) MA44876A (hu)
PL (1) PL3452827T3 (hu)
PT (1) PT3452827T (hu)
SI (1) SI3452827T1 (hu)
UA (1) UA124466C2 (hu)
UY (1) UY37337A (hu)
WO (1) WO2018015463A1 (hu)
ZA (1) ZA201900143B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018203434B4 (de) * 2018-03-07 2019-12-05 Bernd Willi Karl-Heinz Diehl Verfahren zur heteronuklearen quantitativen Bestimmung mittels NMR-Spektroskopie, Referenzsubstanzen hierfür und Verfahren zur Bestimmung des Deuterierungsgrades einer deuterierten Verbindung
CN112816566A (zh) * 2019-11-17 2021-05-18 烟台东诚药业集团股份有限公司 一种那屈肝素钙末端结构确认方法
CN111337529B (zh) * 2020-03-12 2023-06-16 青岛科技大学 一种降低粘度、使水峰偏移的多糖样品制备和测试方法
JP7377937B2 (ja) 2021-10-20 2023-11-10 シオノギヘルスケア株式会社 オリゴ糖の還元末端糖の定量的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519984A (en) 2000-01-07 2004-03-26 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
JP4657726B2 (ja) 2002-05-20 2011-03-23 マサチューセッツ インスティテュート オブ テクノロジー Nmrを使用する配列決定のための新規方法
JP2004339083A (ja) 2003-05-13 2004-12-02 Bioserentack Co Ltd ムコ多糖類製剤
JP2005337958A (ja) 2004-05-28 2005-12-08 Kao Corp 水溶性の糖骨格を有する化合物の分析法
JP2005345193A (ja) 2004-06-01 2005-12-15 Shiseido Co Ltd 核磁気共鳴法及び/又は核磁気共鳴による拡散係数測定法を用いた定量方法
JP2006291028A (ja) 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
US7968082B1 (en) * 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
EP2213282A1 (en) 2009-01-30 2010-08-04 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
ES2340902B1 (es) 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
ES2336297B1 (es) 2008-10-08 2011-01-24 Laboratorios Farmaceuticos Rovi, S.A. Procedimiento de sintesis de pentasacaridos desprotegidos a partir deun pentasacarido precursos protegido.
JP5372696B2 (ja) 2009-10-20 2013-12-18 杏林製薬株式会社 ジメチルアミノエチルメタクリレート含有共重合体の定量法
EP3011043B1 (en) 2013-06-17 2022-05-11 The University of North Carolina At Chapel Hill Reversible heparin molecules

Also Published As

Publication number Publication date
EP3452827A1 (en) 2019-03-13
HRP20211649T1 (hr) 2022-02-04
EA037102B1 (ru) 2021-02-05
US10705037B2 (en) 2020-07-07
PT3452827T (pt) 2021-11-10
PL3452827T3 (pl) 2022-02-14
EA201990005A1 (ru) 2019-06-28
CO2019000087A2 (es) 2019-04-30
BR112019000437A2 (pt) 2019-04-30
US20190154601A1 (en) 2019-05-23
WO2018015463A1 (en) 2018-01-25
AU2017299186C1 (en) 2023-07-06
AU2017299186A1 (en) 2019-01-24
UY37337A (es) 2018-01-31
US10809212B2 (en) 2020-10-20
AU2017299186B2 (en) 2023-04-13
CA3029924A1 (en) 2018-01-25
SI3452827T1 (sl) 2022-01-31
JP2019525166A (ja) 2019-09-05
EP3273239A1 (en) 2018-01-24
CY1124817T1 (el) 2022-11-25
AR109099A1 (es) 2018-10-31
CL2019000038A1 (es) 2019-05-10
CN109477829A (zh) 2019-03-15
LT3452827T (lt) 2021-11-25
WO2018015463A9 (en) 2018-05-11
MA44876A (fr) 2021-04-21
US20200271601A1 (en) 2020-08-27
EP3452827B1 (en) 2021-08-25
CR20190016A (es) 2019-05-17
DK3452827T3 (da) 2021-10-11
ES2894898T3 (es) 2022-02-16
DOP2019000003A (es) 2019-06-30
UA124466C2 (uk) 2021-09-22
ZA201900143B (en) 2019-09-25
CN109477829B (zh) 2022-06-21
JP7035007B2 (ja) 2022-03-14

Similar Documents

Publication Publication Date Title
GB2549676B8 (en) Nuclear magnetic resonance apparatus, systems, and methods
ZA201900143B (en) Method for the analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
EP3073915A4 (en) Apparatus, methods and articles for four dimensional (4d) flow magnetic resonance imaging
ZA201604328B (en) 1,2-naphthoquinone derivative and method for preparing same
EP3171368A4 (en) Method for producing magnetic core, magnetic core, and coil component using same
GB2544350B (en) Nuclear instrumentation system and method for locating the same
EP3131100A4 (en) Magnetic core component, magnetic element, and production method for magnetic core component
IL280148B (en) Methods and device for simulating the interaction of radiation with structures, metrological methods and device, method for preparing the device
EP3142130A4 (en) Core case unit, coil component, and method for producing coil component
EP3282288A4 (en) Radiation measuring apparatus and radiation measuring method
EP3309682A4 (en) DATA ACQUISITION SYSTEM AND METHOD AND METHOD FOR REDUCING THE AMOUNT OF MEASUREMENT DATA
LT3405801T (lt) Elektromagnetinis trikdžių indikatorius ir susijęs būdas
GB2530881B (en) Testing System and Method Using Electromagnetic Near Field Measurements
PL3525630T3 (pl) Rdzeń ze sprężynami kieszeniowymi i sposób wytwarzania rdzenia ze sprężynami kieszeniowymi
PL3091005T3 (pl) Pochodna 1,2-naftochinonu i sposób jej wytwarzania
PL2952502T3 (pl) Bis[3 izopropenylo-alfa, alfa-dimetylobenzylo] karbodiimid, sposób otrzymywania i zastosowanie
PL3187905T3 (pl) System kontroli bezpieczeństwa ciała ludzkiego oraz sposób kontroli bezpieczeństwa ciała ludzkiego przeprowadzany przy użyciu systemu
SG11201708206RA (en) Method for producing super absorber particles
SG11201701354VA (en) Oligosaccharide preparation and method for producing the same
HK1206959A1 (en) Apparatus, system and method for measuring pulse
EP3165276A4 (en) Method for substituting tritium in tritium-containing water, and tritium elimination method
EP3178394A4 (en) Nuclear magnetic resonance imaging system for infants and method imaging thereof
SG11201709794QA (en) System for monitoring and influencing objects of interest and processes carried out by the objects, and corresponding method
HK1220462A1 (zh) -二甲基- -二氫- -喹喔啉- -酮衍生物的製造方法及該製造方法的中間體
PL3251126T3 (pl) Tarcza naświetlana do produkcji radioizotopów, sposób wytwarzania oraz zastosowanie tarczy naświetlanej